Navigation Links
PharmAthene Receives FDA Clearance to Reinitiate Clinical Testing of Valortim®
Date:12/9/2010

n of the Company's product candidates, unexpected funding delays and/or reductions or elimination of U.S. government funding for one or more of the Company's development programs, the award of government contracts to our competitors, unforeseen safety issues, challenges related to the development, scale-up, technology transfer, and/or process validation of manufacturing processes for our product candidates, unexpected determinations that these product candidates prove not to be effective and/or capable of being marketed as products, challenges related to the implementation of our NYSE Amex compliance plan, as well as risks detailed from time to time in PharmAthene's Forms 10-K and 10-Q under the caption "Risk Factors" and in its other reports filed with the U.S. Securities and Exchange Commission (the "SEC").  In particular, at this point there can be no assurance that Valortim® will be shown to be safe and effective and approved by regulatory authorities for use in humans.  

Copies of PharmAthene's public disclosure filings are available from its investor relations department and our website under the investor relations tab at www.PharmAthene.com.


'/>"/>
SOURCE PharmAthene, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. PharmAthene Reports Third Quarter 2010 Financial and Operational Results
2. PharmAthene Receives Four Therapeutic Discovery Project Grants Totaling Approximately $850,000
3. PharmAthene Announces Pricing of $15 Million Public Offering
4. PharmAthene Announces Proposed Common Stock Offering
5. PharmAthene Announces $3.9 Million Registered Direct Offering
6. PharmAthene CEO To Participate on Biosecurity Panel at the 2010 BIO International Conference
7. PharmAthene Appoints Mitchel Sayare, Ph.D. to the Companys Board of Directors
8. PharmAthene Reports Year-End 2009 Financial and Operational Results and Provides Update On Ongoing Litigation With SIGA Technologies
9. PharmAthene to Provide Update on SparVax(TM) Contract Modification Suspension During Year-End 2009 Financial and Operational Results Conference Call on Tuesday March 23, 2010
10. PharmAthene to Host Year-End 2009 Earnings Conference Call and Webcast on Tuesday, March 23, 2010
11. PharmAthene to Present at the 2010 Roth Capital Markets Growth Stock Conference on Monday, March 15, 2010
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/14/2014)... protein functions in a wide variety of ways, including ... protein can take on another form and perform no ... fold wrongly can cause serious diseases such as Alzheimer,s, ... have a tendency to "infect" other molecules of the ... or plaques. These amyloids can damage cells and tissues ...
(Date:9/12/2014)... Switching the polarity of a magnet using an ... a working principle of the next-generation technology for ... candidates for the MEM effect, due to the ... other hand, the coexistence of spontaneous electric and ... hinders the application potential of the MEM effect. ...
(Date:9/12/2014)... 2014 Research and Markets has ... Photoresist Industry Report 2014" report to their offering. ... Report 2014 is a professional and in-depth study on ... industry . The report provides a basic ... industry chain structure. The dry film photoresist market analysis ...
(Date:9/12/2014)... NM (PRWEB) September 12, 2014 Sandia ... an exclusive option agreement with STC.UNM (STC) for a ... Mexico (UNM) in Albuquerque, New Mexico, and Queen Mary ... of technologies, called the Recombinant Fluorescent Antibody Technology Platform ... Department of Internal Medicine and Dr. Angray Kang from ...
Breaking Biology Technology:Measuring modified protein structures 2Measuring modified protein structures 3Global Dry Film Photoresist Industry Report 2014 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 2Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 3Sandia Biotech and STC.UNM Announce Option Agreement to License Novel Recombinant Antibody Technology 4
... the casual observer, responders contained the recent E. coli ... health professionals, the automated system used to identify the ... improvement. , ,Still, information technology played a key role ... and it will play an even greater role in ...
... about your firm? Slow? Fast? Lightning Speed? Not sure? , ... yet to adopt a wiki. A wiki, you ask, what's that? ... Today, it has come to mean a collaborative and group editable ... 2.0 that encourage conversations and draw on the power of social ...
... of change sparked by the information technology industry gives ... business challenge, but has IT really come through for ... recent Wisconsin technology conference, the results are mixed but ... Systems , brought together more than 300 corporate clients ...
Cached Biology Technology:Technology played key role in E. coli alerts 2Technology played key role in E. coli alerts 3Technology played key role in E. coli alerts 4Joining the wiki wacki world 2Joining the wiki wacki world 3Joining the wiki wacki world 4Joining the wiki wacki world 5Are businesses getting what they need from IT? 2Are businesses getting what they need from IT? 3
(Date:9/15/2014)... This news release is available in German . ... of a cell is straightforward: it doubles, divides in ... it has been long assumed that cells of the ... divide symmetrically. Silvia Bulgheresi,s team, University of Vienna, revealed ... long to be perceivable by the naked eye. These ...
(Date:9/15/2014)... in our cells cooperate with one another. But, it ... of different proteins find the correct dancing partners as ... and nervous system. A recent breakthrough at the University ... door and provided a look at the once obscure ... Jens Jrgen Led of the University of Copenhagen,s Department ...
(Date:9/15/2014)... tropical rainforest teeming with life it,s not what comes ... the first time evidence of Doncaster,s 310-million-year-old past, including a ... mining tip. , Some of the fossilised plants and creatures ... the egg case, several horseshoe crabs and some previously unrecorded ... preserved in rocks that formed within the coal and shale ...
Breaking Biology News(10 mins):Think big! Bacteria breach cell division size limit 2Protein courtship revealed through chemist's lens 2Protein courtship revealed through chemist's lens 3'Jaws' lived in Doncaster 2
... University researcher is studying whether the most popular ... in users. There is accumulating evidence that ... including muscle weakness, fatigue and deterioration ... radiology and osteopathic manipulative medicine at MSU. ...
... by a team of scientists using optical probes means ... now be seen in a completely different light. ... working with experts from Glasgow University, and a team ... the way that light was emitted by optical probes ...
... worldwide decline in the number of bees and other ... yields, according to the results of an international study ... journal, Current Biology . , Co-author, CSIRO ... detected warning signs that demand for pollinators is still ...
Cached Biology News:MSU researcher studies ties between cholesterol drugs, muscle problems 2Luminescence shines new light on proteins 2Pollinator decline not reducing crop yields just yet 2
Modified and insect cell culture tested....
BD BaculoGold Max-XP Insect Cell Medium 1 Liter...
Mycoplasma and virus tested...
Bethyl Laboratories Ready-To-Use IHC Bluing Reagent is used following IHC hematoxylin counterstaining with immunohistochemical procedures. Shelf-Life: 1 year from date of receipt...
Biology Products: